Skip to main content
. 2023 Jul;29(7):10.18553/jmcp.2023.22331. doi: 10.18553/jmcp.2023.22331

TABLE 4.

Breakdown of Costs (per Average Patient; Base Case)

Breakdown of costs (USD) NSHE <54 mg/dL NSHE <70 mg/dL
Tubeless AID SoC Tubeless AID SoC
Children
  Total cost 499,539 484,440 553,141 555,624
  Treatment cost 421,275 346,910 421,275 346,910
  Management 3,375 3,167 3,375 3,167
  Cardiovascular disease 27,401 24,653 27,401 24,653
  Renal disease 19,171 24,495 19,171 24,495
  Ulcer/amputation/neuropathy 2,691 2,871 2,691 2,871
  Eye disease 8,984 10,594 8,984 10,594
  NSHE 12,246 19,939 65,848 91,122
  SHE 1 (requiring nonmedical assistance) 139 514 139 514
  SHE 2 (requiring medical assistance)
  DKA 4,258 51,297 4,258 51,297
Adults
  Total cost 441,023 429,558 480,200 488,230
  Treatment cost 350,524 291,438 350,524 291,438
  Management 2,846 2,698 2,846 2,698
  Cardiovascular disease 38,645 37,534 38,645 37,534
  Renal disease 28,472 28,522 28,472 28,522
  Ulcer/amputation/neuropathy 5,243 5,154 5,243 5,154
  Eye disease 6,604 7,100 6,604 7,100
  NSHE 8,562 17,074 47,739 75,745
  SHE 1 (requiring nonmedical assistance) 127 467 127 467
  SHE 2 (requiring medical assistance)
  DKA 39,571 39,571

AID = automated insulin delivery; DKA = diabetic ketoacidosis;

NSHE = nonsevere hypoglycemic event; SHE = severe hypoglycemic event; SoC = standard of care; USD = US dollar.